Patterns of Beliefs About Comorbid Illness Among Patients with COPD Are Associated with Overall Health and Functioning

Author(s):  
A. Federman ◽  
K. Muellers ◽  
Y. Liu ◽  
R. O'Conor ◽  
M.S. Wolf ◽  
...  
Keyword(s):  
2003 ◽  
Vol 124 (4) ◽  
pp. A147
Author(s):  
Charles W. Randall ◽  
Carlo M. Taboada ◽  
Jennifer Kimble

2011 ◽  
Vol 14 (3) ◽  
pp. A202 ◽  
Author(s):  
M. Stewart ◽  
A. Phillips ◽  
N. Edwards ◽  
S. Gupta ◽  
A. Goren

2013 ◽  
pp. 102-131
Author(s):  
Richard J. Hardie ◽  
Jon Poole

This chapter deals mainly with common acute and chronic neurological problems, particularly as they affect employees and job applicants. The complications of occupational exposure to neurotoxins and putative neurotoxins will also be covered in so far as they relate to the fitness of an exposed employee to continue working. In addition to a few well-known and common conditions, many uncommon but distinct neurological disorders may present at work or affect work capacity. Fitness for work in these disorders will be determined by the person’s functional abilities, any comorbid illness, the efficacy or side effects of the treatment, and psychological and social factors, rather than by the precise diagnosis. This will also need to be put into the context of the job in question, as the basic requirements for a manual labouring job may be completely different from something more intellectually demanding. Indeed, even an apparently precise diagnostic label such as multiple sclerosis (MS) can encompass a complete spectrum of disability, from someone who is entirely asymptomatic to another who is totally incapacitated. Similarly, the job title ‘production operative’ may be applied to someone who is sedentary or who undertakes heavy manual handling. Furthermore, reports by general practitioners, neurologists, or neurosurgeons may describe the symptoms, signs, and investigations in detail, but without analysing functional abilities. These colleagues may also fail to appreciate the workplace hazards, the responsibilities of the employer, or what scope exists for adaptations to the job or workplace.


2019 ◽  
Vol 3 (Supplement_1) ◽  
pp. S483-S483
Author(s):  
Aparna Vadlamani ◽  
Jennifer Albrecht

Abstract Patient reported history of comorbid illness may be the only information available to the treatment team during an acute injury admission. Nevertheless, acute injury, particularly traumatic brain injury (TBI) which affects cognition, may decrease the patient’s ability to accurately report medical history. Thus, the objective of this study was to evaluate the accuracy of patient-reported comorbid illness burden compared to the patient’s Medicare administrative claims. Records of older adults treated for TBI at an urban level 1 trauma center 2006-2010 were linked to their Medicare administrative. Comorbidities were recorded in Medicare claims based on ICD9 codes and were reported in the trauma registry (TR) based on patient medical history recorded by a physician or nurse. Prevalence of each of the following comorbidities was calculated using information from the TR and claims: Alzheimer’s disease and related dementias, chronic kidney disease, COPD, heart failure, diabetes, depression, stroke, and hypertension. Sensitivity of each patient-reported comorbidity was calculated using Medicare claims as the gold standard. We identified patient factors associated with accurate self-report using logistic regression. Among 408 older adults with TBI that linked to their Medicare claims, prevalence of each comorbidity was higher in Medicare claims compared to the TR, except for hypertension. Sensitivity for detecting these comorbidities using the TR ranged from 2% to 68%, with the highest sensitivity observed for hypertension. Older age and race were predictors of less accurate reported medical history. Reconciling self-reported patient history of these comorbidities with those reported in claims can better inform decisions regarding treatment.


2013 ◽  
Vol 85 (5) ◽  
pp. 1246-1253 ◽  
Author(s):  
Daniel A. Hamstra ◽  
Matt H. Stenmark ◽  
Tim Ritter ◽  
Dale Litzenberg ◽  
William Jackson ◽  
...  

2012 ◽  
Vol 18 (8) ◽  
pp. S76
Author(s):  
Christopher S. Lee ◽  
Julie T. Bidwell ◽  
Quin E. Denfeld ◽  
Ruth Masterson Creber ◽  
Jill M. Gelow ◽  
...  

2004 ◽  
Vol 78 (1) ◽  
pp. 73-80 ◽  
Author(s):  
Barbara Bell ◽  
Lori Chalklin ◽  
Michael Mills ◽  
Gina Browne ◽  
Meir Steiner ◽  
...  

2012 ◽  
Vol 36 (2) ◽  
pp. 325-326
Author(s):  
M L Vetter ◽  
T A Wadden ◽  
J Lavenberg ◽  
R H Moore ◽  
S Volger ◽  
...  

Author(s):  
Chetan Shenoy ◽  
Gretchen Kimmick

Overview: As new therapies improve survival from cancer, attention to comorbid illness and complications of therapy—both short- and long-term—become much more important to improving not only quality of life but also overall survival. Recognized for its importance as the leading cause of death in the United States, heart disease often coexists with cancer, and cancer treatment may increase risk and/or severity. In addition, there are well-recognized cardiovascular toxicities of cancer treatment, including not only cardiomyopathy, but also hypertension, hypercholesterolemia, and others. Oncologists and cardiologists are working closely to learn more about the complex interaction and to improve management and outcome for patients.


2009 ◽  
Vol 44 (18) ◽  
pp. 22-22
Author(s):  
Mark Moran
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document